Incidence of pneumomediastinum in COVID-19: A single-center comparison between 1st and 2nd wave.

Respir Investig · 2021 · PMC8162722 · PMID 34108126

Europe PMC DOI

hedged sentences

0.0390

closest p · 0.8× alpha

0.0500

boldest claim

The sentences

clearly significantp = 0.039actually significant

When restricting the analysis to patients who developed pneumomediastinum during noninvasive ventilation, the difference became clearly significant (0.17/1000 vs 1.36/1000 patient-days, p = 0.039).

also in 480 other papers

quasi-significantp = 0.05actually significant

Crude incidence was higher during the 2nd wave at a quasi-significant level (0.68/1000 vs. 2.05/1000 patient-days, p = 0.05).

also in 64 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.